$439 Million is the total value of Endurant Capital Management LP's 53 reported holdings in Q3 2021. The portfolio turnover from Q2 2021 to Q3 2021 was 66.7% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| SPY | New | SPDR S&P 500 ETF TRput | $73,812,000 | – | 25,300 | +100.0% | 16.81% | – |
| New | INVACARE CORPnote 5.000%11/1 | $51,196,000 | – | 56,727,000 | +100.0% | 11.66% | – | |
| New | TRILLIUM THERAPEUTICS INCcall | $36,314,000 | – | 206,800 | +100.0% | 8.27% | – | |
| ABBV | Buy | ABBVIE INC | $19,463,000 | +102.1% | 180,429 | +111.0% | 4.43% | +67.4% |
| HUM | Buy | HUMANA INC | $17,131,000 | +145.0% | 44,022 | +178.8% | 3.90% | +103.1% |
| JNJ | Buy | JOHNSON & JOHNSON | $15,839,000 | +191.4% | 98,077 | +197.2% | 3.61% | +141.4% |
| HOLX | Buy | HOLOGIC INC | $14,771,000 | +99.7% | 200,119 | +80.5% | 3.36% | +65.6% |
| BIO | Buy | BIO RAD LABS INCcl a | $13,630,000 | +79.0% | 18,272 | +54.6% | 3.10% | +48.3% |
| BMY | Buy | BRISTOL-MYERS SQUIBB CO | $12,533,000 | +85.6% | 211,821 | +109.6% | 2.85% | +53.8% |
| ICLR | Sell | ICON PLC | $12,242,000 | -25.4% | 46,720 | -41.2% | 2.79% | -38.2% |
| THC | Sell | TENET HEALTHCARE CORP | $11,912,000 | -18.4% | 179,288 | -17.7% | 2.71% | -32.4% |
| SIBN | Buy | SI-BONE INC | $10,093,000 | +698.5% | 471,214 | +1073.5% | 2.30% | +562.2% |
| SYNH | Sell | SYNEOS HEALTH INCcl a | $8,115,000 | -30.4% | 92,761 | -28.8% | 1.85% | -42.3% |
| VCYT | Buy | VERACYTE INC | $7,813,000 | +39.4% | 168,211 | +20.0% | 1.78% | +15.4% |
| CI | Sell | CIGNA CORP NEW | $7,243,000 | -57.5% | 36,188 | -49.6% | 1.65% | -64.8% |
| AZYO | Buy | AZIYO BIOLOGICS INC | $6,625,000 | -21.0% | 952,610 | +9.1% | 1.51% | -34.6% |
| AVTR | Buy | AVANTOR INC | $6,624,000 | +22.4% | 161,963 | +6.3% | 1.51% | +1.4% |
| MCK | New | MCKESSON CORP | $6,490,000 | – | 32,551 | +100.0% | 1.48% | – |
| OMI | Buy | OWENS & MINOR INC NEW | $6,376,000 | +124.8% | 203,784 | +204.2% | 1.45% | +86.4% |
| RCM | Sell | R1 RCM INC | $6,227,000 | -49.0% | 282,911 | -48.5% | 1.42% | -57.7% |
| New | INVACARE CORPnote 5.000%11/1 | $6,207,000 | – | 7,000,000 | +100.0% | 1.41% | – | |
| ATR | New | APTARGROUP INC | $6,110,000 | – | 51,191 | +100.0% | 1.39% | – |
| OCUL | Buy | OCULAR THERAPEUTIX INC | $6,104,000 | -24.6% | 610,401 | +6.9% | 1.39% | -37.5% |
| LH | Sell | LABORATORY CORP AMER HLDGS | $5,299,000 | -69.5% | 18,829 | -70.1% | 1.21% | -74.7% |
| ADAP | Sell | ADAPTIMMUNE THERAPEUTICS PLCsponds adr | $4,743,000 | -27.7% | 917,488 | -40.4% | 1.08% | -40.1% |
| AHCO | New | ADAPTHEALTH CORP | $4,539,000 | – | 194,886 | +100.0% | 1.03% | – |
| INSM | Sell | INSMED INC | $4,404,000 | -40.6% | 159,903 | -38.6% | 1.00% | -50.7% |
| SELB | Buy | SELECTA BIOSCIENCES INC | $4,249,000 | +9.7% | 1,021,501 | +10.2% | 0.97% | -9.1% |
| MTEM | Sell | MOLECULAR TEMPLATES INC | $4,117,000 | -29.6% | 613,630 | -18.0% | 0.94% | -41.7% |
| ALBO | Buy | ALBIREO PHARMA INC | $3,661,000 | +0.5% | 117,328 | +13.3% | 0.83% | -16.7% |
| PHAS | Sell | PHASEBIO PHARMACEUTICALS INC | $3,522,000 | -55.5% | 1,132,523 | -46.8% | 0.80% | -63.2% |
| XRAY | Sell | DENTSPLY SIRONA INC | $3,519,000 | -46.4% | 60,620 | -41.6% | 0.80% | -55.6% |
| PKI | New | PERKINELMER INC | $3,338,000 | – | 19,264 | +100.0% | 0.76% | – |
| IOVA | Sell | IOVANCE BIOTHERAPEUTICS INC | $3,233,000 | -22.5% | 131,098 | -18.2% | 0.74% | -35.8% |
| PRAX | Sell | PRAXIS PRECISION MEDICINES I | $2,840,000 | -22.1% | 153,599 | -23.0% | 0.65% | -35.5% |
| BDX | New | BECTON DICKINSON & CO | $2,723,000 | – | 11,077 | +100.0% | 0.62% | – |
| SNY | New | SANOFIsponsored adr | $2,643,000 | – | 54,821 | +100.0% | 0.60% | – |
| ABC | Sell | AMERISOURCEBERGEN CORP | $2,560,000 | -46.4% | 21,430 | -48.6% | 0.58% | -55.6% |
| RGLS | Buy | REGULUS THERAPEUTICS INC | $2,450,000 | +15.6% | 3,547,208 | +36.0% | 0.56% | -4.3% |
| BLU | Sell | BELLUS HEALTH INC NEW | $2,394,000 | +89.4% | 389,833 | -4.1% | 0.54% | +57.1% |
| Sell | DARIOHEALTH CORP | $2,048,000 | -62.9% | 150,004 | -42.0% | 0.47% | -69.3% | |
| MREO | Sell | MEREO BIOPHARMA GROUP PLCads | $1,807,000 | -24.7% | 746,514 | -1.4% | 0.41% | -37.6% |
| AXSM | New | AXSOME THERAPEUTICS INC | $1,716,000 | – | 52,048 | +100.0% | 0.39% | – |
| IMUX | Buy | IMMUNIC INC | $1,641,000 | -24.4% | 185,448 | +4.7% | 0.37% | -37.4% |
| MRVI | New | MARAVAI LIFESCIENCES HLDGS I | $1,464,000 | – | 29,838 | +100.0% | 0.33% | – |
| ACRS | Sell | ACLARIS THERAPEUTICS INC | $1,211,000 | -42.2% | 67,300 | -43.6% | 0.28% | -52.1% |
| KRYS | New | KRYSTAL BIOTECH INC | $1,198,000 | – | 22,938 | +100.0% | 0.27% | – |
| BOLT | New | BOLT BIOTHERAPEUTICS INC | $1,139,000 | – | 90,041 | +100.0% | 0.26% | – |
| ALVR | New | ALLOVIR INC | $1,113,000 | – | 44,430 | +100.0% | 0.25% | – |
| XENE | New | XENON PHARMACEUTICALS INC | $959,000 | – | 62,743 | +100.0% | 0.22% | – |
| PDCO | New | PATTERSON COS INC | $808,000 | – | 26,799 | +100.0% | 0.18% | – |
| CYAD | Sell | CELYAD ONCOLOGY SAadr | $596,000 | -29.5% | 145,380 | -9.5% | 0.14% | -41.4% |
| IVC | Sell | INVACARE CORP | $323,000 | -97.1% | 1,146,068 | -16.6% | 0.07% | -97.6% |
| XFOR | Exit | X4 PHARMACEUTICALS INC | $0 | – | -70,969 | -100.0% | -0.13% | – |
| PRVB | Exit | PROVENTION BIO INC | $0 | – | -82,960 | -100.0% | -0.19% | – |
| CANO | Exit | CANO HEALTH INC | $0 | – | -62,013 | -100.0% | -0.21% | – |
| VRTX | Exit | VERTEX PHARMACEUTICALS INC | $0 | – | -7,553 | -100.0% | -0.42% | – |
| FBRX | Exit | FORTE BIOSCIENCES INC | $0 | – | -53,369 | -100.0% | -0.49% | – |
| PNTG | Exit | PENNANT GROUP INC | $0 | – | -47,475 | -100.0% | -0.53% | – |
| BAX | Exit | BAXTER INTL INC | $0 | – | -25,059 | -100.0% | -0.55% | – |
| SRPT | Exit | SAREPTA THERAPEUTICS INC | $0 | – | -28,625 | -100.0% | -0.61% | – |
| TFX | Exit | TELEFLEX INCORPORATED | $0 | – | -7,501 | -100.0% | -0.83% | – |
| REGN | Exit | REGENERON PHARMACEUTICALS | $0 | – | -5,563 | -100.0% | -0.85% | – |
| MDVL | Exit | MEDAVAIL HOLDINGS INC | $0 | – | -292,196 | -100.0% | -0.98% | – |
| CALT | Exit | CALLIDITAS THERAPEUTICS ABsponsered ads | $0 | – | -144,393 | -100.0% | -1.17% | – |
| SBTX | Exit | SILVERBACK THERAPEUTICS INC | $0 | – | -139,124 | -100.0% | -1.18% | – |
| FATE | Exit | FATE THERAPEUTICS INC | $0 | – | -51,031 | -100.0% | -1.22% | – |
| ANTM | Exit | ANTHEM INC | $0 | – | -11,941 | -100.0% | -1.25% | – |
| Exit | INSMED INCnote 0.750% 6/0 | $0 | – | -5,000,000 | -100.0% | -1.52% | – | |
| Exit | TRILLIUM THERAPEUTICS INC | $0 | – | -600,788 | -100.0% | -1.60% | – | |
| EAR | Exit | EARGO INC | $0 | – | -193,471 | -100.0% | -2.12% | – |
| HAE | Exit | HAEMONETICS CORP MASS | $0 | – | -117,904 | -100.0% | -2.16% | – |
| TMO | Exit | THERMO FISHER SCIENTIFIC INC | $0 | – | -29,679 | -100.0% | -4.12% | – |
| Exit | INVACARE CORPnote 5.000%11/1 | $0 | – | -37,566,000 | -100.0% | -10.07% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-11-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| LABORATORY CORP AMER HLDGS | 31 | Q2 2023 | 8.7% |
| ELEVANCE HEALTH INC | 29 | Q3 2023 | 8.8% |
| BECTON DICKINSON & CO | 28 | Q2 2023 | 9.8% |
| MCKESSON CORP | 27 | Q1 2023 | 4.4% |
| CENCORA INC | 26 | Q3 2023 | 5.9% |
| HOLOGIC INC | 24 | Q3 2023 | 7.5% |
| JOHNSON & JOHNSON | 24 | Q4 2021 | 5.5% |
| ZIMMER HLDGS INC | 23 | Q3 2023 | 7.5% |
| BOSTON SCIENTIFIC CORP | 22 | Q3 2023 | 5.5% |
| DAVITA INC | 22 | Q1 2021 | 4.9% |
View Endurant Capital Management LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| AZIYO BIOLOGICS, INC. | March 21, 2023 | 576,253 | 4.9% |
| Oxford Immunotec Global PLCSold out | February 17, 2021 | 0 | 0.0% |
View Endurant Capital Management LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13D/A | 2024-04-10 |
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| SC 13D/A | 2023-09-08 |
| 13F-HR | 2023-08-14 |
| 3/A | 2023-05-24 |
| 13F-HR | 2023-05-15 |
| 3 | 2023-05-15 |
| SC 13D | 2023-05-15 |
| SC 13G/A | 2023-03-21 |
View Endurant Capital Management LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.